Post by Teva Pharmaceuticals

Excited to be recognized at the Medicines for Europe Annual Conference for our Health Equity and Access to Medicines initiative. For us, it means turning commitment into action. In 2025, we've: • Provided 21.5 million doses of medicine through our 8 strategic access programs • Reached ~8 million patients through product donations • Supported ~400,000 beneficiaries through health system strengthening initiatives While we're honored by this recognition, we're even more motivated by the impact behind the numbers. Because every patient matters, and access to healthcare shouldn't depend on where you live. A special thanks to Michal Nitka, SVP Head Generics Europe & Global Head OTC, for accepting the recognition on behalf of Teva.